- 暂无数据
简体中文
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, LPKF Laser, a leading supplier of innovative laser solutions in Germany, released its performance report for the first half of the 2024 fiscal year as of June 30, demonstrating the company's steady performance and forward-looking layout in a complex market environment. According to the financial report, LPKF Laser&Electronics SE achieved significant growth in comprehensive revenue ...
Recently, the research team of Dong Hongxing and Zhang Long from the Research Center of Infrared Optical Materials of the Chinese Academy of Sciences Shanghai Institute of Optics and Precision Mechanics, in cooperation with Huazhong University of Science and Technology, reported a new mechanism for generating dynamically tunable single-mode lasers from exciton polaritons with ultra-low thresholds,...
Lithography is one of the core processes in semiconductor manufacturing, and extreme ultraviolet lithography technology, as a new generation lithography technology, is also in a rapid development stage. The basic principle is to use photoresist (also known as photoresist) to form corrosion resistance due to photochemical reactions after being photosensitive, and to engrave the patterns on the mask...
German researchers have developed a method for controlling and manipulating optical signals by embedding liquid crystal layers into waveguides created by direct laser writing. This work has produced devices capable of electro-optic control of polarization, which may open up possibilities for chip based devices and complex photonic circuits based on femtosecond write waveguides.Researcher Alexandro...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...